Company Analysis
Sign in

Zevra Therapeutics, Inc. (ZVRA)

Nasdaq: ZVRA · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2008
Full chart Alerts Compare
Grade5.6
◀ Past 4.5● Present 5.8▶ Future 6.1
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 9, 2026Mar 12, 2025Apr 1, 2024Mar 7, 2023Mar 31, 2022Mar 12, 2021Feb 28, 2020Mar 1, 2019Mar 30, 2018Mar 10, 2017
Revenue106,47023,61227,46110,161r28,65013,28812,8390··
Cost of revenue16,4827,4172,173222r2,059·10,0000··
Research and development12,74342,09539,80619,803r10,1618,84319,41541,75920,59320,472
Selling, general and administrative77,61654,86834,31415,038······
General and administrative···15,3438,7017,92110,81612,50812,77314,000
Total operating expenses·······55,90333,36637,482
Total costs and expenses90,35996,96374,120r52,726r20,92118,89733,17655,903··
Operating income-62,943-87,003-49,604-42,565r7,729-5,609-20,337-55,903-33,366-37,482
Interest expense7,9777,3511,5013352264,7854,8585,4695,7765,511
Total non-operating income (expense)149,621-3,1373,55515,760r-16,250-7,185-4,207-689-10,06320,951
Income before income taxes86,678-90,140-46,049-26,805r-8,521-12,794-24,544-56,592-43,429-16,531
Income tax expense3,44915,3710-33r34-34-22-126-43-15
Net income83,229-105,511-46,049-26,772r-8,555-12,760-24,522-56,466-43,386-16,516
Preferred dividends00·054,3420····
Net income to common shareholders77,585-105,511-46,049-26,772r-62,897-12,760····
Earnings per share, basic1.40-2.28-1.30-0.78r-2.11-3.21····
Earnings per share, diluted1.35-2.28··-2.11-3.21····
Earnings per share, basic and diluted·····-3.21-13.23r-3.15-2.96-1.13
Weighted average shares, basic55,311,30846,251,23935,452,46034,488,80029,766,3473,980,975····
Weighted average shares, diluted57,262,71546,251,239··29,766,3473,980,975····
Weighted average shares, basic and diluted·····3,980,9751,853,397r17,930,02314,652,89814,597,053
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
us-gaap:CostOfRevenue
us-gaap:CostOfGoodsAndServicesSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton ZVRA · research, not advice